SynthesisJournal of cancer research and clinical oncology2023

Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials.

Zeinab Davoodi-Moghaddam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.